Growth Metrics

Solid Biosciences (SLDB) Gains from Investment Securities (2018 - 2025)

Quarterly results put Gains from Investment Securities at $85000.0 for Q4 2025, up 4350.0% from a year ago — trailing twelve months through Mar 2026 was $105000.0 (up 129.66% YoY), and the annual figure for FY2025 was $4.4 million, up 49.53%.

Solid Biosciences has reported Gains from Investment Securities over the past 8 years, most recently at $85000.0 for Q4 2025.

  • Gains from Investment Securities reached $85000.0 in Q4 2025 per SLDB's latest filing, down from $4.4 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $4.4 million in Q3 2025 and bottomed at -$374000.0 in Q4 2023.
  • Median Gains from Investment Securities over the past 5 years was $266277.0 (2021), compared with a mean of $612641.5.
  • The largest annual shift saw Gains from Investment Securities plummeted 100.31% in 2021 before it skyrocketed 10222.76% in 2023.
  • Over 5 years, Gains from Investment Securities stood at $319000.0 in 2021, then tumbled by 97.37% to $8380.0 in 2022, then crashed by 4563.01% to -$374000.0 in 2023, then soared by 99.47% to -$2000.0 in 2024, then soared by 4350.0% to $85000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SLDB at $85000.0 in Q4 2025, $4.4 million in Q3 2025, and $103882.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 85,000.00
Dec 31, 2025 85,000.00
Sep 30, 2025 4.38 Mn
Sep 30, 2025 4.38 Mn
Jun 30, 2025 103,882.00
Jun 30, 2025 103,882.00
Mar 31, 2025 22,000.00
Mar 31, 2025 22,000.00
Dec 31, 2024 -2,000.00
Dec 31, 2024 -2,000.00
Sep 30, 2024 2.94 Mn
Sep 30, 2024 2.94 Mn
Jun 30, 2024 421,148.00
Jun 30, 2024 421,148.00
Mar 31, 2024 601,402.00
Mar 31, 2024 601,402.00
Dec 31, 2023 -374,000.00
Dec 31, 2023 -374,000.00
Sep 30, 2023 865,047.00
Sep 30, 2023 865,047.00
Mar 31, 2023 347,997.00
Mar 31, 2023 347,997.00
Sep 30, 2022 8,380.00
Sep 30, 2022 8,380.00
Jun 30, 2022 301,905.00
Jun 30, 2022 301,905.00
Mar 31, 2022 174,738.00
Mar 31, 2022 174,738.00
Dec 31, 2021 319,000.00
Dec 31, 2021 319,000.00
Sep 30, 2021 230,649.00
Sep 30, 2021 230,649.00
Jun 30, 2021 604,400.00
Jun 30, 2021 604,400.00
Mar 31, 2021 -3,000.00
Mar 31, 2021 -3,000.00
Dec 31, 2020 3.12 Mn
Dec 31, 2020 3.12 Mn
Sep 30, 2020 41,440.00
Sep 30, 2020 41,440.00
Jun 30, 2020 436,065.00
Jun 30, 2020 436,065.00
Mar 31, 2020 957,655.00
Mar 31, 2020 957,655.00
Sep 30, 2019 1.66 Mn
Sep 30, 2019 1.66 Mn
Jun 30, 2019 101,000.00
Jun 30, 2019 101,000.00
Mar 31, 2019 1.54 Mn
Mar 31, 2019 1.54 Mn
Dec 31, 2018 -7,000.00
Dec 31, 2018 -7,000.00
Sep 30, 2018 32,009.00
Sep 30, 2018 32,009.00
Jun 30, 2018 752,773.00
Jun 30, 2018 752,773.00
Mar 31, 2018 558,105.00
Mar 31, 2018 558,105.00